FGF13 Is a Novel Regulator of NF-κB and Potentiates Pathological Cardiac Hypertrophy
Jia Sun(Zhujiang Hospital), Xiaokun Li(Peking University Shenzhen Hospital), Weijian Ye(Wenzhou Medical University), Xixi Chen(Wenzhou Medical University), Xiaozhong Huang(Agency for Science, Technology and Research), Yingjie Shen(Huzhou University), Ning An(Guangdong Medical College), Ying Wáng(Shanghai Center For Bioinformation Technology), Xu Wang(Xiamen University), Jianan Wang(Jiangnan University), Chao Niu(Wenzhou Medical University), Gen Chen(Wenzhou Medical University), Yang Wang(Shenyang Agricultural University), Weitao Cong(Wenzhou Medical University), Shuai Huang(First Affiliated Hospital of Zhengzhou University), Litai Jin(Wenzhou Medical University)
Cited by 32
Related Papers
Mesenchymal Stem Cells in Fibrotic Disease
|Cell stem cell|2017|451
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits
|Proceedings of the National Academy of Sciences|2000|383
Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction
|Circulation Research|2011|274
Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury
|Circulation|2005|200
Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis
|Frontiers in Pharmacology|2019|195